AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dotzide-M Tablet

Prescription Icon
Prescription Required

Marketer

Three Dots Lifescience

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Dotzide-M Tablet

Diabetam Duo tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetam Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continue this medication even if feeling well or achieving satisfactory blood sugar control; abrupt cessation, without physician consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one element of a comprehensive diabetes management plan including diet, exercise, and weight management as prescribed by your doctor. Lifestyle choices are crucial in diabetes control. The most frequent side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors, constipation, and vomiting. Learn to recognize and manage hypoglycemia; maintain regular meals and carry a rapid-acting glucose source like sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects are altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor of any prior heart conditions before commencing treatment, as it may be contraindicated. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Dotzide-M Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Dotzide-M Tablet

Adult-onset diabetes

Major Benefits of Dotzide-M Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dotzide-M Tablet with a meal.

Common Side effects of Dotzide-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Dotzide-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Dotzide-M Tablet with a meal.

How Dotzide-M Tablet works:

Gliclazide and metformin are combined in Dotzide-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dotzide-M Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dotzide-M tablets during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Dotzide-M tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when prescribing Dotzide-M tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients should seek medical guidance. Dotzide-M tablets are contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dotzide-M Tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. A low initial dosage is typically prescribed for individuals with mild to moderate liver disease; however, Dotzide-M Tablets are contraindicated in those with severe hepatic dysfunction.

What if you forget to take Dotzide-M Tablet :

Should you forget a Dotzide-M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dotzide-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dotzide-M Tablet

Dotzide-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Dotzide-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Dotzide-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Dotzide-M Tablet use can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Dotzide-M Tablet and seek immediate medical attention.
Prolonged Dotzide-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Dotzide-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Dotzide-M Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Dotzide-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Dotzide-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Dotzide-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Dotzide-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely to occur if you avoid using the medication if you have kidney disease, are elderly, or consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these symptoms, discontinue Dotzide-M and seek immediate medical attention.
Prolonged Dotzide-M Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Dotzide-M Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Dotzide-M tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Dotzide-M Tablet
53
MRP 61
13% off